» Authors » Tana Machackova

Tana Machackova

Explore the profile of Tana Machackova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 412
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Budinska E, Carnogurska M, Catela Ivkovic T, Machackova T, Boudna M, Pifkova L, et al.
Front Oncol . 2024 May; 14:1367231. PMID: 38706608
Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage...
2.
Boudna M, Machackova T, Vychytilova-Faltejskova P, Trachtova K, Bartosova R, Catela Ivkovic T, et al.
Clin Exp Med . 2024 Apr; 24(1):67. PMID: 38568288
Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate...
3.
Boudna M, Campos A, Vychytilova-Faltejskova P, Machackova T, Slaby O, Souckova K
Cell Commun Signal . 2024 Mar; 22(1):171. PMID: 38461237
This review presents a comprehensive overview of labelling strategies for endogenous and exogenous extracellular vesicles, that can be utilised both in vitro and in vivo. It covers a broad spectrum...
4.
Sustr F, Machackova T, Pesl M, Svacinova J, Trachtova K, Starek Z, et al.
Mol Diagn Ther . 2024 Mar; 28(3):301-310. PMID: 38459249
Background: Catheter ablation (CA) of atrial fibrillation (AF) is indicated in patients with recurrent and symptomatic AF episodes. Despite the strict inclusion/exclusion criteria, AF recurrence after CA remains high. Identification...
5.
Vychytilova-Faltejskova P, Vilmanova S, Pifkova L, Catela Ivkovic T, Mdrzyk M, Jugas R, et al.
Clin Chem Lab Med . 2023 Jul; 62(1):157-167. PMID: 37505924
Objectives: Small extracellular vesicles (EVs) contain various signaling molecules, thus playing a crucial role in cell-to-cell communication and emerging as a promising source of biomarkers. However, the lack of standardized...
6.
Kiss D, Machackova T, Souckova K, Fabian P, Krepelkova I, Svoboda M, et al.
In Vivo . 2021 Aug; 35(5):2809-2814. PMID: 34410972
Background/aim: The monoclonal antibody bevacizumab is a standard drug used in combination with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) based chemotherapy in the first or second-line treatment of metastatic colorectal cancer...
7.
Novak J, Machackova T, Krejci J, Bienertova-Vasku J, Slaby O
Theranostics . 2021 Apr; 11(12):6058-6073. PMID: 33897899
Congestive heart failure affects about 23 million people worldwide, and cardiac allograft transplantation remains one of the last options for patients with terminal refractory heart failure. Besides the infectious or...
8.
Parimuchova A, Dusatkova L, Kovac L, Machackova T, Slaby O, Pekar S
Sci Rep . 2021 Mar; 11(1):4994. PMID: 33654189
Trophic interactions of cave arthropods have been understudied. We used molecular methods (NGS) to decipher the food web in the subterranean ecosystem of the Ardovská Cave (Western Carpathians, Slovakia). We...
9.
Machackova T, Vychytilova-Faltejskova P, Souckova K, Trachtova K, Brchnelova D, Svoboda M, et al.
Cancers (Basel) . 2020 Dec; 12(12). PMID: 33255928
Growing evidence suggests that miR-215-5p is a tumor suppressor in colorectal cancer (CRC); however, its role in metastasis remains unclear. This study evaluates the effects of miR-215 overexpression on the...
10.
Machackova T, Trachtova K, Prochazka V, Grolich T, Farkasova M, Fiala L, et al.
Cancer Genomics Proteomics . 2020 Apr; 17(3):249-257. PMID: 32345666
Background/aim: Rectal cancer accounts for approximately one-third of all colorectal cancers. Currently, the standard treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (CRT) with capecitabine or 5-fluorouracil followed...